These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9519150)

  • 1. Myocardial effect compartment modeling of metoprolol and sotalol: importance of myocardial subsite drug concentration.
    Ritchie RH; Morgan DJ; Horowitz JD
    J Pharm Sci; 1998 Feb; 87(2):177-82. PubMed ID: 9519150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
    Luzier AB; Killian A; Wilton JH; Wilson MF; Forrest A; Kazierad DJ
    Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive and negative inotropic effects of DL-sotalol and D-sotalol in failing and nonfailing human myocardium under physiological experimental conditions.
    Holubarsch C; Schneider R; Pieske B; Ruf T; Hasenfuss G; Fraedrich G; Posival H; Just H
    Circulation; 1995 Nov; 92(10):2904-10. PubMed ID: 7586258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetic-pharmacodynamic modeling of metoprolol enantiomers in the dog].
    Yin XX; Zhang YD
    Yao Xue Xue Bao; 1997 Jun; 32(6):411-5. PubMed ID: 11596322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic modeling of metoprolol stereoisomers in spontaneously hypertensive rat.
    Yin XX; Zhang YD; Luo JP; Huang XP; Shen JP; Ding Y; Huang DK
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):104-8. PubMed ID: 10072957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promising approach for the preclinical assessment of cardiac risks using left ventricular pressure-volume loop analyses in anesthetized monkeys.
    Ishizaka T; Yoshimatsu Y; Maeda Y; Takasaki W; Chiba K; Mori K
    J Pharmacol Toxicol Methods; 2017; 84():1-10. PubMed ID: 27756610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term myocardial uptake of d- and l-sotalol in humans: relation to hemodynamic and electrophysiologic effects.
    Ritchie RH; Sallustio BC; Hii JT; Horowitz JD
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):876-84. PubMed ID: 9641472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic profiles of d-sotalol and d,l-sotalol.
    Funck-Brentano C
    Eur Heart J; 1993 Nov; 14 Suppl H():30-5. PubMed ID: 7904936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle-aged subjects.
    Barbey JT; Sale ME; Woosley RL; Shi J; Melikian AP; Hinderling PH
    Clin Pharmacol Ther; 1999 Jul; 66(1):91-9. PubMed ID: 10430114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of the negative inotropic effects of metoprolol at short cycle lengths in humans: comparison with sotalol and verapamil.
    Ritchie RH; Zeitz CJ; Wuttke RD; Hii JT; Horowitz JD
    J Am Coll Cardiol; 2006 Sep; 48(6):1234-41. PubMed ID: 16979012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sotalol. Beta-blockade and class III antiarrhythmic effect].
    Bjørnstad H; Refsum H
    Tidsskr Nor Laegeforen; 1990 Nov; 110(29):3763-5. PubMed ID: 1980382
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitivity of pharmacokinetic-pharmacodynamic analysis for detecting small magnitudes of QTc prolongation in preclinical safety testing.
    Gotta V; Cools F; van Ammel K; Gallacher DJ; Visser SA; Sannajust F; Morissette P; Danhof M; van der Graaf PH
    J Pharmacol Toxicol Methods; 2015; 72():1-10. PubMed ID: 25556117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postextrasystolic potentiation in patients with ischaemic heart disease: influence of inotropic agents.
    Zhang YI; Ritchie RH; Horowitz JD
    Br J Clin Pharmacol; 1995 Jul; 40(1):25-30. PubMed ID: 8527264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance to the repolarization effects of rac-sotalol during long-term treatment.
    Padrini R; Gusella M; Al Bunni M; Piovan D; Zordan R; Magnolfi G; Maiolino P; Ferrari M
    Br J Clin Pharmacol; 1997 Nov; 44(5):463-70. PubMed ID: 9384463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose pharmacokinetics of sotalol in a pediatric population with supraventricular and/or ventricular tachyarrhythmia.
    Saul JP; Schaffer MS; Karpawich PP; Erickson CC; Epstein MR; Melikian AP; Shi J; Karara AH; Cai B; Hinderling PH
    J Clin Pharmacol; 2001 Jan; 41(1):35-43. PubMed ID: 11144992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study.
    Kochiadakis GE; Kanoupakis EM; Kalebubas MD; Igoumenidis NE; Vardakis KE; Mavrakis HE; Vardas PE
    Europace; 2001 Jan; 3(1):73-9. PubMed ID: 11271956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inotropic and haemodynamic effects of d- and d,l-sotalol: comparison with other antiarrhythmics.
    Seipel L; Hoffmeister HM
    Eur Heart J; 1993 Nov; 14 Suppl H():36-40. PubMed ID: 7904937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applicability of microdialysis as a technique for pharmacokinetic-pharmacodynamic (PK-PD) modeling of antihypertensive beta-blockers.
    Höcht C; DiVerniero C; Opezzo JA; Taira CA
    J Pharmacol Toxicol Methods; 2005; 52(2):244-50. PubMed ID: 16125622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between acute myocardial uptake and hemodynamic and electrocardiographic effects of metoprolol in humans.
    Ritchie RH; Wuttke RD; Stafford I; Horowitz JD
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):57-65. PubMed ID: 7511736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacokinetic-pharmacodynamic model of d-sotalol Q-Tc prolongation during intravenous administration to healthy subjects.
    Salazar DE; Much DR; Nichola PS; Seibold JR; Shindler D; Slugg PH
    J Clin Pharmacol; 1997 Sep; 37(9):799-809. PubMed ID: 9549633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.